Katia Boutourlinsky, Alexandre Croquelois, Dominique Boucher, Sara Bizzotto, Jamel Chelly, Grazia Maria Mancini, Egbert Welker, Camino de Juan Romero, Anne-Gaëlle Le Moing, Jean-François Deleuze, Wassila Carpentier, Renske Oegema, Richard Belvindrah, Karine Poirier, Michel Kielar, Robert Olaso, Nadia Bahi-Buisson, Fiona Francis, Cécile Lebrand, Françoise Phan Dinh Tuy, Víctor Borrell, Patrick Berquin, Institut du Fer à Moulin, Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Plateforme Post-génomique de la Pitié-Salpêtrière ( P3S ), UMS omique ( OMIQUE ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Pierre et Marie Curie - Paris 6 ( UPMC ), Institut Cochin ( UM3 (UMR 8104 / U1016) ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Inserm Avenir program, French Agence National de la Recherche [ANR-08-MNP-013, ANR-13-BSV4-0008-01], Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Plateforme Post-génomique de la Pitié-Salpêtrière (P3S), UMS omique (OMIQUE), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Pierre et Marie Curie - Paris 6 (UPMC), Institut Cochin (IC UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Clinical Genetics, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC), Agence Nationale de la Recherche (France), Fondation Bettencourt Schueller, Fédération pour la Recherche sur le Cerveau (France), Swiss National Science Foundation, European Commission, Fondation pour la Recherche Médicale, and Ministerio de Economía y Competitividad (España)
Neuronal migration disorders such as lissencephaly and subcortical band heterotopia are associated with epilepsy and intellectual disability. DCX, PAFAH1B1 and TUBA1A are mutated in these disorders; however, corresponding mouse mutants do not show heterotopic neurons in the neocortex. In contrast, spontaneously arisen HeCo mice display this phenotype, and our study revealed that misplaced apical progenitors contribute to heterotopia formation. While HeCo neurons migrated at the same speed as wild type, abnormally distributed dividing progenitors were found throughout the cortical wall from embryonic day 13. We identified Eml1, encoding a microtubule-associated protein, as the gene mutated in HeCo mice. Full-length transcripts were lacking as a result of a retrotransposon insertion in an intron. Eml1 knockdown mimicked the HeCo progenitor phenotype and reexpression rescued it. We further found EML1 to be mutated in ribbon-like heterotopia in humans. Our data link abnormal spindle orientations, ectopic progenitors and severe heterotopia in mouse and human., We thank the Inserm Avenir program, the French Agence National de la Recherche (ANR-08-MNP-013 (F.F.), ANR-13-BSV4-0008-01 (F.F.), ANR Blanc 1103-01 (J.C.), projet R11039KK, ANR E-Rare Program, convention 2011-RaARE-012-01) (J.C.), the Fondation Bettencourt Schueller and the Federation pour la recherche sur le cerveau (FRC) for grants awarded to F.F., the FRC Rotary for an equipment grant awarded to the Institut du Fer à Moulin, the Swiss National Science Foundation (SNSF 31003A-135574, SPUM-33CM30-124089 and 33CM30-140332) and the Fondation Gianni Biaggi de Blasys for grants awarded to A.C., and the SNSF (31003A-125379) for grants awarded to E.W. The research leading to a part of these results received funding from the European Union Seventh Framework Programme FP7/2007–2013 under the project DESIRE (grant agreement no. 602531), la Fondation pour la Recherche Médicale (FRM, J Chelly–Equipe FRM 2013: DEQ2000326477) la Fondation Jacques Espinasse & Danièle (JED)-Belgique and the Spanish Ministry of Economy and Competitiveness grant (BFU2012-33473) awarded to V.B.